Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402–405.
Hansford S, Kaurah P, Li-Chang H, et al. Heredritary diffuse gastric cancer syndrome CDH1 mutations and beyond. JAMA Oncol 2015; 1: 23–32.
Mi EZ, Mi EZ, di Pietro M, et al. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status. Gastrointest Endosc 2017; 87: 408–418.
Peitz U, Vieth M, Evert M, et al. The prevalence of gastric heterotopia of the proximal esophagus is underestimated, but preneoplasia is rare - correlation with Barrett’s esophagus. BMC Gastroenterol 2017; 17: 87.
Orosey M, Amin M, Cappell MS., A 14-year study of 398 esophageal adenocarcinomas diagnosed among 156,256 egds performed at two large hospitals: an inlet patch is proposed as a significant risk factor for proximal esophageal adenocarcinoma. Dig Dis Sci 2018; 63: 452–465.
Jadot V, Segers K, Bours V, et al. [Hereditary diffuse gastric cancer: case serie of 8 patients from a single family and literature review]. Rev Med Liege 2019; 74: 134–138.
van der Post RS, Vogelaar IP, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 2015; 52: 361–374.
Dunn JM, Sui G, Anggiansah A, et al. Radiofrequency ablation of symptomatic cervical inlet patch using a through-the-scope device: a pilot study. Gastrointest Endosc 2016; 84: 1022–1026.e2.
Meining A, Bajbouj M, Preeg M, et al. Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trial. Endoscopy 2006; 38: 566–570.
Klare P, Meining A, von Delius S, et al. Argon plasma coagulation of gastric inlet patches for the treatment of globus sensation: it is an effective therapy in the long term. Digestion 2013; 88: 165–171.